ArticleNMR in biomedicine2026
Noise-Level Adaptive Diffusion Priors for Zero-Shot Low-Field MRI Quality Enhancement.
Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Low-field MRI (LF-MRI) improves imaging accessibility, but its practical utility is often limited by reduced signal-to-noise ratio, weaker tissue contrast, and variable image quality. These challenges are further compounded by the limited availability of low-field training data across scanners and the fact that raw k-space data are not always accessible in research and clinical workflows. In this study, we adapted a high-field-trained diffusion model for LF-MRI quality enhancement without low-field retraining or fine-tuning. During inference, the pretrained diffusion prior was combined with noise-level adaptive measurement guidance to suppress low-field noise while maintaining consistency with measurement-supported anatomical structures. With phase augmentation, this framework was further extended to magnitude-only DICOM-exported inputs when measured phase information was unavailable. The method was evaluated on 10 locally recruited healthy volunteers scanned at 0.05, 0.3, and 3 T, a public 0.064-T healthy-subject dataset with 10 paired cases, and patient cases acquired at 0.05 and 0.35 T. Compared with raw LF input and representative baselines including BM3D, MiDiffusion, and NAFNet, the proposed method (Nila) improved visual image quality, noise suppression, and tissue contrast, while preserving lesion-region appearance in patient cases. On the 0.3 and 0.064 T datasets with coregistered 3-T references, Nila achieved the best LPIPS and the highest or tied-highest NMI across contrasts, indicating improved similarity to the high-field reference. Multisample posterior inference further produced uncertainty maps that provide an explainable-AI view of spatial output variability, with elevated variance mainly localized to tissue boundaries and ambiguous regions. These results suggest that high-field diffusion priors can serve as practical and reusable tools for LF-MRI enhancement across heterogeneous systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.